Leaderboards/liver disease diagnosis and treatment

liver disease diagnosis and treatment

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Dror Dicker
Unknown
90
2
Vincent Chen
University of Michigan
80
3
W. Ray Kim
WinnMed
70
4
Hans Gelderblom
Leiden University Medical Center
60
5
Vinod Ravi
Unknown
50
6
Mohammed Eslam
The University of Sydney
40
7
Stephen A. Harrison
University of Oxford
30
8
M. Scott Harris
Altimmune (United States)
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Shuang Zeng
Dalian University of Technology
90
2
Salma Mostafa Mohamed
Cairo University
70
3
Jiao Zhai
City University of Hong Kong
60
4
Simran Thakur
Maharishi Markandeshwar University, Mullana
50
5
Hans Gelderblom
Leiden University Medical Center
40
6
Hina Wazir
Khyber Medical College
20

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Morris Sherman
University Health Network
99
2
Arun J. Sanyal
Virginia Commonwealth University Medical Center
90
3
Jorge A. Marrero
The University of Texas Southwestern Medical Center
80
4
Michel P. Coleman
London School of Hygiene & Tropical Medicine
70
5
Paul Angulo
Mayo Clinic
60
6
Victor de Lédinghen
Inserm
40
7
Eric P. Krenning
Erasmus MC
30
8
Alastair D. Smith
Duke Medical Center
20
9
Rohit Loomba
University of California, San Diego
10

All-Time Leaders Papers

1
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Hepatology|2017
7.2k cit.
2
AASLD guidelines for the treatment of hepatocellular carcinoma
Hepatology|2017
4.1k cit.
3
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Hepatology|2017
2.4k cit.
4
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
Hepatology|2017
1.9k cit.
5
A lipidomic analysis of nonalcoholic fatty liver disease
Hepatology|2007
1.3k cit.
6
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
Hepatology|2017
369 cit.
7
Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease
PLoS ONE|2015
136 cit.
8
Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis
Cell Death and Differentiation|2014
45 cit.

Indexing liver disease diagnosis and treatment Reagents

Citation data for reagents in this field is currently compiling.